Europe Artificial Blood Market: By Product Type (Hemoglobin-Based Oxygen Carriers, Perflurocarbon-Based Products, Recombinant Factors, Synthetic Platelets, Plasma Expanders, Others), By Application (Traumatic Injuries, Blood Disorders, Anemia, Surgeries, Others), By Distribution Channel (Hospitals, Clinics, Blood Banks), and Geography    

Purchase Option

$ 3000
$ 4400
$ 4600
$ 6900

Artificial blood or synthetic blood and blood products are the alternatives to the blood transfusion to replace the blood. It fulfills and replicates the normal functions of the body. Artificial blood is infused in the traumatic injuries and other disease conditions for the transportation of carbon di oxide and oxygen across the body. Moreover, scientists are focusing on the development of artificial blood due to inadequate number of blood donors leads to shortage of blood. However, there are adverse effects associated with the artificial blood such as hemoglobin based blood substitute might increase the occurrence of heart attacks.

Europe Artificial Blood Market Summary

Study Period

2023-29

Base Year

2022

CAGR

X%

Largest Market

N/A

Fastest Growing Market

N/A
Europe Artificial Blood Market Dynamics

Drivers: Increase in the prevalence of anemia and other blood disorders Rise in R&D for the innovation of newer products Increase in healthcare expenditure and well developed healthcare infrastructure Restraints: Lower shelf-life and instability of artificial blood Adverse effects associated with artificial blood substitutes Stringent regulatory guidelines for product approval

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Europe Artificial Blood Market Segmentation

product type
  • Hemoglobin-Based Oxygen Carriers
  • Perflurocarbon-Based Products
  • Recombinant Factors
  • Synthetic Platelets
  • Plasma Expanders
  • Others
By Application
  • Traumatic Injuries
  • Blood Disorders
  • Anemia
  • Surgeries
  • Others
Distribution Channel
  • Hospitals
  • Clinics
  • Blood Banks

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Plasticell Limited (U.K.)